Split History
ETFs Holding DVAX »    DVAX Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Dynavax Technologies is a commercial stage biopharmaceutical company engaged in developing and commercializing vaccines. Co.'s primary marketed product, Hepatitis B Vaccine (Recombinant), Adjuvanted (HEPLISAV-B), is approved in the U.S. and European Union for prevention of infection caused by known subtypes of hepatitis B virus in adults age 18 years and older. Co. also manufactures and sells CpG oligonucleotide (CpG) 1018 adjuvant, the vaccine adjuvant used in HEPLISAV-B. Co. developed CpG 1018 adjuvant to provide an increased vaccine immune response. According to our DVAX split history records, Dynavax Technologies has had 1 split.
DVAX split history picture
Dynavax Technologies (DVAX) has 1 split in our DVAX split history database. The split for DVAX took place on November 10, 2014. This was a 1 for 10 reverse split, meaning for each 10 shares of DVAX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.

When a company such as Dynavax Technologies conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the DVAX split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Dynavax Technologies shares, starting with a $10,000 purchase of DVAX, presented on a split-history-adjusted basis factoring in the complete DVAX split history. DVAX split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 02/01/2013
End date: 01/30/2023
Start price/share: $31.10
End price/share: $11.41
Dividends collected/share: $0.00
Total return: -63.31%
Average Annual Total Return: -9.54%
Starting investment: $10,000.00
Ending investment: $3,669.15
Years: 10.00
Date Ratio
11/10/20141 for 10
DVAX is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

DXCM Split History
DYN Split History
DYNT Split History
EAR Split History
ECTE Split History
EHC Split History
EIGR Split History
EKSO Split History
ELGX Split History
ELOX Split History

Also explore: DVAX shares outstanding history

Email EnvelopeFree DVAX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Liminal BioSciences Inc. (LMNL)
Galway Metals Inc. (GWM.CA)
Lannett Company, Inc. (LCI)
Reed's, Inc. (REED)
Phio Pharmaceuticals Corp. (PHIO)
Swvl Holdings Corp (SWVL)
Sientra, Inc. (SIEN)
Eargo, Inc. (EAR)
Alterity Therapeutics Limited (ATHE)
Aytu BioPharma, Inc. (AYTU)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

DVAX Insider Buying

DVAX Split History | www.SplitHistory.com | Copyright © 2013 - 2023, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.